Normal structural brain development in adolescents treated for perinatally acquired HIV: a longitudinal imaging study

Malon Van den Hof1, Pien E J Jellema1, Anne Marleen Ter Haar1

  • 1Emma Children's Hospital, Pediatric Infectious Diseases.

AIDS (London, England)
|March 12, 2021
PubMed

Insights

Adolescents with perinatally acquired HIV (PHIV) on long-term treatment show largely normal structural brain development over time. Follow-up MRI revealed no significant differences in white matter or grey matter volumes compared to HIV-negative peers.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Infectious Diseases

Background:

  • Cross-sectional studies indicate lower brain volumes and white matter integrity in children with perinatally acquired HIV (PHIV).
  • Previous research on the NOVICE cohort highlighted these structural differences in PHIV-positive children compared to controls.

Purpose of the Study:

  • To longitudinally investigate changes in brain structure over time in adolescents with PHIV.
  • To determine if initial differences in white matter and grey matter volumes persist or change during adolescence.

Main Methods:

  • Follow-up MRI scans were conducted on participants from the NOVICE cohort after approximately 4.6 years.
  • Measurements included total white matter and grey matter volume, white matter hyperintensities (WMH) volume, and white matter integrity using T1-weighted, FLAIR, and DTI sequences.
  • Multivariable linear mixed effects models were used to compare rates of change between PHIV-positive and HIV-negative groups, adjusting for sex and age.

Main Results:

  • No statistically significant differences in the rate of change were observed between groups for white matter volume, WMH volume, or white matter integrity.
  • A trend suggested that total grey matter volume decreased significantly less in the PHIV group, but this finding lost statistical significance after adjusting for height.
  • No HIV-associated determinants for reduced grey matter pruning or associations with cognitive development were identified.

Conclusions:

  • Adolescents with PHIV receiving long-term antiretroviral therapy exhibit largely normal structural brain development.
  • The study suggests that current treatment strategies may mitigate long-term structural brain abnormalities in this population.
Abstract